RxDoctor Payments Data

John Marks, MD

Colon & Rectal Surgery · Wynnewood, PANPI 1346212594

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 54 manufacturers reported payments, led by Intuitive Surgical at 28.7% of the total. 2025 is the largest year on record at $44,911, 2.0 times the $22,045 reported in 2019. Among colon & rectal surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$154,564in general payments, 2019–2025

Across 237 payments — averaging $652.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$44K
  • Vascular Technology, Inc.$35K
  • Stryker$30K
  • Arthrex$24K
  • Medtronic$14K
  • Covidien LP$3K
  • plus $5K from 48 others
$322,149in research payments, 2019–2025

Across 2 payments — averaging $161,074 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Olympus America Inc.$322K

What the payments were for

  • Consulting fees$84,16554%
  • Speaking & faculty fees$43,65028%
  • Travel & lodging$9,4216%
  • Food & beverage$9,3046%
  • Education$8,0005%
  • Gifts$240%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$154,564 in reported general payments places this provider in the 95th percentile of 108 colon & rectal surgery providers in Pennsylvania.

See all colon & rectal surgery providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$200,788
Medicare patients
370
Services billed
883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate77$301
Dicyclomine Hcl14$216

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Wynnewood

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →